White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effectiveness of Dexlansoprazole for Treating Nonerosive GERD in Children Aged 2 to 11 Years

Not recruiting

2 1 1
Investigated Diseases:
- Gastrooesophageal reflux disease
Investigated Drugs:
- Dexlansoprazole
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Not recruiting

3 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Deucravacitinib
+2
Study on Dexlansoprazole for Treating and Maintaining Healing of Erosive Esophagitis in Children Aged 2 to 11 Years

Not recruiting

2 1 1
Investigated Diseases:
- Erosive oesophagitis
Investigated Drugs:
- Dexlansoprazole
Study on the Long-term Effects of Methylone for Treating PTSD in Patients

Not recruiting

2 1 1
Investigated Diseases:
- Post-traumatic stress disorder
Investigated Drugs:
- Methylone
Study of Tamibarotene, Venetoclax, and Azacitidine for Adults with RARA-positive Acute Myeloid Leukemia Not Eligible for Standard Therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study Comparing Pralsetinib and Standard Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Lung neoplasm malignant
- Non-small cell lung cancer
Investigated Drugs:
+4
Study on the Safety and Effectiveness of 166Holmium Radiation Therapy with Atezolizumab and Bevacizumab for Patients with Non-Resectable Liver Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Not recruiting

3 1 1
Investigated Drugs:
- Evolocumab
+16
Study on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension

Not recruiting

3 1 1
Investigated Diseases:
- Hypertension
Investigated Drugs:
- Lorundrostat
- Tetracosactide
+2
Study on the Safety and Effectiveness of Ibrutinib for Children and Young Adults with Chronic Graft Versus Host Disease

Not recruiting

1 1 1 1
Investigated Diseases:
- Chronic graft versus host disease
Investigated Drugs:
- Ibrutinib
- Prednisone

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies